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Conjugated Linoleic Acid Metabolism and
Body Fat Loss in Mice
Kim M. Hargrave
Brett J. Meyer
Jess L. Miner1
Summary
Mice were fed conjugated lino-
leic acid (CLA) with or without fish
oil or aspirin, which deplete tissue
arachidonic acid and block arachi-
donic acid metabolism, respec-
tively. Mice fed fish oil did not lose
body fat when supplemented with
CLA but mice fed soy oil did. Aspi-
rin did not alter CLA-induced body
fat loss. CLA may be metabolized to
an isomer of arachidonic acid to
induce a loss of body fat. However,
this body fat loss is apparently not
mediated via alteration of prostag-
landin synthesis. Understanding
the regulation of body fat by CLA
may offer insight into the mecha-
nisms of body fat regulation in
cattle.
Introduction
Conjugated linoleic acid (CLA)
refers to a group of isomers of
linoleic acid which have multiple
health benefits. The cis-9,trans-11
isomer is produced naturally and
deposited in the fat of ruminant
animals. The CLA isomers can be
metabolized like linoleic acid to
longer-chain conjugated fatty acids
including isomers of arachidonic
acid. We previously reported (2002
Nebraska Beef Report, pp 92-93)
that mice consuming a diet defi-
cient in essential fatty acids (li-
noleic and linolenic acids) lost
more body fat when supplemented
with CLA than did control mice.
While the cis-9,trans-11 isomer has
no effect on body fatness, it does
have other health benefits includ-
ing prevention and treatment of cer-
tain cancers. Since this isomer can
be metabolized similarly to the
trans-10,cis-12 isomer responsible
for the loss of body fat, understand-
ing the metabolism of one isomer
may contribute to our knowledge of
how several of the isomers induce
biological effects. In addition, the
regulation of body fat deposition is
largely not understood but essential
to our ability to alter that deposi-
tion. Therefore, our first objective
was to determine the effect of modu-
lating the dietary concentration of
essential fatty acids (linoleic, lino-
lenic, and arachidonic acids) on
CLA-induced body fat loss.
Arachidonic acid is a precursor
to the series 2 prostaglandins via
metabolism by cyclooxygenase and
the series 4 leukotrienes via
metabolism by lipoxygenase. It is
unknown if CLA, metabolized to a
conjugated isomer of arachidonic
acid, interferes with the normal
conversion of arachidonic acid to
prostaglandins or leukotrienes, or if
conjugated eicosanoids are formed.
Aspirin is a known inhibitor of
cyclooxygenase. Our second objec-
tive was to determine if altering
arachidonic acid metabolism by
inhibiting cyclooxygenase would
alter CLA-induced body fat loss.
Procedure
Experiment 1
Eighty newly weaned male mice
were fed either a control diet (20%
soy oil) or a fish oil diet (20% men-
haden fish oil) for 6 weeks. Half of
each group was subsequently
supplemented with 0.5% CLA,
replacing either soy or fish oil, for
an additional 2 weeks. The mice
then were killed and the retroperito-
neal fat pads, epididymal fat pads
and livers were weighed and col-
lected. Body fat and lean mass were
determined by dual x-ray densitom-
etry.
Experiment 2
Eighty male mice (9 weeks of
age) were fed either a control (7%
soy oil), CLA (6% soy oil + 1%
CLA), aspirin (control + 400 mg/kg
diet aspirin), or aspirin+CLA (CLA
diet + 400 mg/kg diet aspirin) diet
for 2 weeks. Mice were killed and
tissues were collected as in Experi-
ment 1.
Results
Experiment 1
Adipose tissue from mice fed fish
oil had a greater concentration of
long-chain n-3 polyunsaturated
fatty acids and arachidonic acid
and less linoleic and linolenic acids
than those fed soy oil (Table 1).
Neither fish oil feeding nor the
addition of CLA affected feed intake
or body weight. Feeding either fish
oil or CLA reduced (P < 0.05) body
fat compared to control (Figure 1).
However, fat source by CLA inter-
action was observed (P < 0.01); mice
fed fish oil + CLA were not leaner
than mice fed fish oil or CLA alone.
Similar results were observed in fat
pad weights. Fish oil-fed mice also
had heavier (P < 0.001) livers and
greater (P < 0.05) lean mass than
soy oil-fed mice.
We hypothesized that feeding a
basal fat source with altered essen-
tial fatty acid concentrations would
alter the sensitivity to CLA-induced
body fat loss. We previously
reported support of this hypothesis,
in that a greater loss of body fat was
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of arachidonic acid that then
results in the body fat loss observed
in mice.
Experiment 2
The addition of CLA to the diet
of mice resulted in reduced feed
intake (P < 0.05) during both weeks
and reduced body weight following
week 2 (P < 0.01). Aspirin feeding
increased week 2-body weight
(P < 0.01). CLA supplementation
reduced body fat by 26% (P < 0.001)
while aspirin had no effect (Figure
2). Similar results were observed
in fat pad weights. CLA also
increased liver weight (P < 0.001)
and lean mass (P < 0.01) regardless
of aspirin supplementation.
In our previous report and with
Experiment 1 in this report, we
indicated adipose tissue arachi-
donic acid concentration may be
negatively correlated with the CLA-
induced loss of body fat in mice.
However, inhibition of arachidonic
acid metabolism to the series 2
prostaglandins via cyclooxygenase
did not affect CLA-induced body fat
loss. Arachidonic acid is also
metabolized to leukotrienes via
lipoxygenase. Therefore a conju-
gated isomer of arachidonic acid
may still interfere with arachidonic
acid metabolism, but not at the level
of cyclooxygenase.
Although the CLA isomer
present in ruminant products, cis-
9,trans-11, does not result in altered
body fatness it does block cancer
growth. This isomer can also be
metabolized similarly to linoleic
acid and the trans-10,cis-12 isomer
that is responsible for the loss of
body fat. Therefore, determining the
pathway through which one CLA
isomer induces a biological effect
will give insight into the mecha-
nism by which other isomers func-
tion.
1Kim Hargrave, graduate student;
Brett Meyer, former undergraduate
student; Jess Miner, associate professor,
Animal Science, Lincoln.
Table 1. Effect of fish oil and/or conjugated linoleic acid (CLA) on fatty acid
concentrations in retroperitoneal fat pads, Experiment 1.
Fish Oil+
Fatty Acid, %a Controlb CLAb Fish Oilb CLAb SEMc
C18:2 n-6 50.67d 48.30d 8.94e 10.98e 1.701
C18:3 n-3 3.43d 2.48e 1.67f 1.78f 0.107
C20:4 n-6 0.08e 0.06e 0.29d 0.28d 0.021
C20:5 n-3 0.02e 0.10e 1.22d 1.13d 0.121
C22:6 n-3 0.01e 0.02e 0.38d 0.38d 0.040
cis-9,trans-11 CLA 0.02e 0.34d 0.07e 0.48d 0.061
trans-10,cis-12 CLA 0.00e 0.30e 0.96d 0.89d 0.110
aFatty acids were analyzed by gas chromatography and expressed as a percentage of
total fatty acids.
bControl (20% soy oil); CLA (19.5% soy oil + 0.5% CLA); Fish oil (20% menhaden fish
oil); Fish oil+CLA (19.5% menhaden fish oil + 0.5% CLA).
cSEM = Standard error of the means.
defDifferent letters within a row indicate differences, P < 0.05.
Figure 1. Effect of fish oil and (or) conjugated linoleic acid (CLA) on body fat,
Experiment 1. Control (20% soy oil), CLA (19.5% soy oil + 0.5% CLA), Fish
oil (20% menhaden fish oil), and Fish oil+CLA (19.5% menhaden fish oil +
0.5% CLA). abMeans with different superscripts differ, P < 0.01.
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observed in mice when both linoleic
and arachidonic acids were
reduced by feeding coconut oil
(2002 Nebraska Beef Report, pp. 92-
93). However in this experiment, no
CLA-induced loss of body fat was
observed when arachidonic acid
concentration was increased by
feeding fish oil, although this diet
also reduced linoleic acid concen-
tration. Therefore, CLA may be
metabolized to a conjugated isomer
Figure 2. Effect of aspirin and (or) conjugated linoleic acid (CLA) on body fat,
Experiment 2. Control (7% soy oil), CLA (6% soy oil + 1% CLA), Aspirin
(control diet + 400 mg/kg aspirin), Aspirin+CLA (CLA diet + 400 mg/kg
aspirin). abMeans with different superscripts differ, P < 0.001.
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